News Business30 Sep 2004

Foreign Drug Firms' Special Status May Increase Medical Expenses

30 Sep 2004

A new set of draft amendments applied to the Pharmaceutical Affairs Law will cause the domestic pharmaceutical industry to lose about NT$4 billion (US$117.3 million) in its annual production value during a five-year period and an increase of NT$3.5 billion (US$102.7 million) in medical expenses under the national health insurance programme.

Archived articles are available to Magazine subscribers only.

If you are already a subscriber

OR sign-up for a trial access here

For Full Access to the magazine SUBSCRIBE here.

Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.

Error : Object reference not set to an instance of an object.

Recent Comments

Other News

Follow Asia Insurance Review